Track topics on Twitter Track topics that are important to you
French R&D company Valbiotis has reported positive results from a Phase I/II study of VAL 070 for the treatment of...Read More... The post Valbiotis reports positive data from Phase I/II study of ...
VALBIOTIS presence increased in the USA, following the U.S. patent obtained for VALEDIATM and the authorization of the multicentric international study REVERSE IT gra...
Investors welcome VALBIOTIS' initial public offering in 2017 85,000 votes for the 18th edition of this Award organized by Boursorama Regulatory ...
Last subject included in the the Phase IIA clinical study at the beginning of November 2018 Results to be published mid-2019, as precedently announced ...
Appointed Head of Development and Medical Affairs. In charge of the acceleration of the international clinical development of VALEDIA®, its industrial p...
VALBIOTIS develops leading expertise in this field of research VALBIOTIS compiles a base of human data in the field of metabolic diseases, with high valu...
VALBIOTIS is a French Research & Development company committed to scientific innovation, for preventing and fighting against metabolic diseases. Its products are made for manufact...
We have published hundreds of VALBIOTIS news stories on BioPortfolio along with dozens of VALBIOTIS Clinical Trials and PubMed Articles about VALBIOTIS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of VALBIOTIS Companies in our database. You can also find out about relevant VALBIOTIS Drugs and Medications on this site too.
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...